title: [The use of L-DOPA for treating myocardial infarct patients].
abstract: Clinical and experimental studies showed a high therapeutic activity of L-DOPA in combination with traditional methods of infarction treatment. L-DOPA promoted a rapid disappearance of heart failure symptoms and accelerated reparative processes by restoring the activity of the sympathetic nervous system. Correctness of the experimentally developed basically new scheme for administration of neurotropic drugs to patients with infarction depending on the disease stage has been validated.
authors.forename: V V
authors.initials: VV
authors.lastname: Bul'on
authors.forename: L K
authors.initials: LK
authors.lastname: Khnychenko
authors.forename: I S
authors.initials: IS
authors.lastname: Zavodskaia
authors.forename: L I
authors.initials: LI
authors.lastname: Levina
authors.forename: I S
authors.initials: IS
authors.lastname: Reznikova
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Fedorov
mesh_terms: D000328:Adult; D002395:Catecholamines / Q000652:urine; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D010993:Plethysmography, Whole Body; D012074:Remission Induction
chemical_list: D002395:Catecholamines; D007980:Levodopa
vernacular_title: Primenenie L-DOFA dlia lecheniia bol'nykh infarktom miokarda.